The Biosimilar Revolution: Addressing Cost and Access in the Biopharmaceuticals Market
A major structural shift is occurring in the Biopharmaceuticals Market with the rapid entry and acceptance of biosimilars, which are highly similar and therapeutically equivalent versions of expensive, originator biological drugs whose patents have expired, and the push for biosimilars is a critical strategy by both governments and payers to introduce cost competition, improve patient access,...
0 Comments 0 Shares 269 Views 0 Reviews
SMG https://sharemeglobal.com